Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
Xylose utilization stimulates mitochondrial production of isobutanol and 2-methyl-1-butanol in .

Biotechnology for biofuels

Zhang Y, Lane S, Chen JM, Hammer SK, Luttinger J, Yang L, Jin YS, Avalos JL.
PMID: 31548865
Biotechnol Biofuels. 2019 Sep 20;12:223. doi: 10.1186/s13068-019-1560-2. eCollection 2019.

BACKGROUND: Branched-chain higher alcohols (BCHAs), including isobutanol and 2-methyl-1-butanol, are promising advanced biofuels, superior to ethanol due to their higher energy density and better compatibility with existing gasoline infrastructure. Compartmentalizing the isobutanol biosynthetic pathway in yeast mitochondria is an...

Cite
Zhang Y, Lane S, Chen JM, et al. Xylose utilization stimulates mitochondrial production of isobutanol and 2-methyl-1-butanol in . Biotechnol Biofuels. 2019;12:223doi: 10.1186/s13068-019-1560-2.
Zhang, Y., Lane, S., Chen, J. M., Hammer, S. K., Luttinger, J., Yang, L., Jin, Y. S., & Avalos, J. L. (2019). Xylose utilization stimulates mitochondrial production of isobutanol and 2-methyl-1-butanol in . Biotechnology for biofuels, 12223. https://doi.org/10.1186/s13068-019-1560-2
Zhang, Yanfei, et al. "Xylose utilization stimulates mitochondrial production of isobutanol and 2-methyl-1-butanol in ." Biotechnology for biofuels vol. 12 (2019): 223. doi: https://doi.org/10.1186/s13068-019-1560-2
Zhang Y, Lane S, Chen JM, Hammer SK, Luttinger J, Yang L, Jin YS, Avalos JL. Xylose utilization stimulates mitochondrial production of isobutanol and 2-methyl-1-butanol in . Biotechnol Biofuels. 2019 Sep 20;12:223. doi: 10.1186/s13068-019-1560-2. eCollection 2019. PMID: 31548865; PMCID: PMC6753614.
Copy Download .nbib Format: NLM
A Multidisciplinary Approach to Optimizing Long-Term Functional Prognosis of A Girl With Quadriceps Fibrosis.

Journal of rehabilitation medicine. Clinical communications

Luthringer J, Garetier M, Lempereur M, Houx L, Burdin V, Ropars J, Salem DB, Printemps C, Brochard S, Pons C.
PMID: 34276901
J Rehabil Med Clin Commun. 2021 May 10;4:1000054. doi: 10.2340/20030711-1000054. eCollection 2021.

The consequences and optimal treatment of quadriceps fibrosis following intramuscular quinine injection during childhood remain unclear. We report here a case of a 17-year-old girl who experienced unilateral quadriceps fibrosis following intramuscular injection of quinine as a baby. This...

Cite
Luthringer J, Garetier M, Lempereur M, et al. A Multidisciplinary Approach to Optimizing Long-Term Functional Prognosis of A Girl With Quadriceps Fibrosis. J Rehabil Med Clin Commun. 2021;4:1000054doi: 10.2340/20030711-1000054.
Luthringer, J., Garetier, M., Lempereur, M., Houx, L., Burdin, V., Ropars, J., Salem, D. B., Printemps, C., Brochard, S., & Pons, C. (2021). A Multidisciplinary Approach to Optimizing Long-Term Functional Prognosis of A Girl With Quadriceps Fibrosis. Journal of rehabilitation medicine. Clinical communications, 41000054. https://doi.org/10.2340/20030711-1000054
Luthringer, Jessica, et al. "A Multidisciplinary Approach to Optimizing Long-Term Functional Prognosis of A Girl With Quadriceps Fibrosis." Journal of rehabilitation medicine. Clinical communications vol. 4 (2021): 1000054. doi: https://doi.org/10.2340/20030711-1000054
Luthringer J, Garetier M, Lempereur M, Houx L, Burdin V, Ropars J, Salem DB, Printemps C, Brochard S, Pons C. A Multidisciplinary Approach to Optimizing Long-Term Functional Prognosis of A Girl With Quadriceps Fibrosis. J Rehabil Med Clin Commun. 2021 May 10;4:1000054. doi: 10.2340/20030711-1000054. eCollection 2021. PMID: 34276901; PMCID: PMC8205268.
Copy Download .nbib Format: NLM
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?.

Innovations in clinical neuroscience

Daniel DG, Kott A, Saoud J, Luthringer R, Rud V, Skyrpnikov A, Stan R, Palazov V, Wang X, Davidson M.
PMID: 32547844
Innov Clin Neurosci. 2020 Jan 01;17(1):27-29.

No abstract available.

Cite
Daniel DG, Kott A, Saoud J, et al. Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?. Innov Clin Neurosci. 2020;17(1):27-29
Daniel, D. G., Kott, A., Saoud, J., Luthringer, R., Rud, V., Skyrpnikov, A., Stan, R., Palazov, V., Wang, X., & Davidson, M. (2020). Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?. Innovations in clinical neuroscience, 17(1), 27-29.
Daniel, David G, et al. "Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?." Innovations in clinical neuroscience vol. 17,1 (2020): 27-29.
Daniel DG, Kott A, Saoud J, Luthringer R, Rud V, Skyrpnikov A, Stan R, Palazov V, Wang X, Davidson M. Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?. Innov Clin Neurosci. 2020 Jan 01;17(1):27-29. PMID: 32547844; PMCID: PMC7239560.
Copy Download .nbib Format: NLM
Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.

Translational psychiatry

Recourt K, de Boer P, Zuiker R, Luthringer R, Kent J, van der Ark P, Van Hove I, van Gerven J, Jacobs G, van Nueten L, Drevets W.
PMID: 31578318
Transl Psychiatry. 2019 Oct 02;9(1):240. doi: 10.1038/s41398-019-0585-4.

In the original Article, Tables two and three had formatting issues which affected their clarity. This has been corrected in the PDF and HTML versions of this Article.

Cite
Recourt K, de Boer P, Zuiker R, et al. Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Transl Psychiatry. 2019;9(1):240doi: 10.1038/s41398-019-0585-4.
Recourt, K., de Boer, P., Zuiker, R., Luthringer, R., Kent, J., van der Ark, P., Van Hove, I., van Gerven, J., Jacobs, G., van Nueten, L., & Drevets, W. (2019). Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Translational psychiatry, 9(1), 240. https://doi.org/10.1038/s41398-019-0585-4
Recourt, Kasper, et al. "Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder." Translational psychiatry vol. 9,1 (2019): 240. doi: https://doi.org/10.1038/s41398-019-0585-4
Recourt K, de Boer P, Zuiker R, Luthringer R, Kent J, van der Ark P, Van Hove I, van Gerven J, Jacobs G, van Nueten L, Drevets W. Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Transl Psychiatry. 2019 Oct 02;9(1):240. doi: 10.1038/s41398-019-0585-4. PMID: 31578318; PMCID: PMC6775147.
Copy Download .nbib Format: NLM
Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment.

Dialogues in clinical neuroscience

Macher JP, Luthringer R, Staner L.
PMID: 22033557
Dialogues Clin Neurosci. 2004 Mar;6(1):78-81.

No abstract available.

Cite
Macher JP, Luthringer R, Staner L. Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment. Dialogues Clin Neurosci. 2004;6(1):78-81
Macher, J. P., Luthringer, R., & Staner, L. (2004). Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment. Dialogues in clinical neuroscience, 6(1), 78-81.
Macher, Jean-Paul, et al. "Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment." Dialogues in clinical neuroscience vol. 6,1 (2004): 78-81.
Macher JP, Luthringer R, Staner L. Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment. Dialogues Clin Neurosci. 2004 Mar;6(1):78-81. PMID: 22033557; PMCID: PMC3181791.
Copy Download .nbib Format: NLM
Human models as tools in the development of psychotropic drugs.

Dialogues in clinical neuroscience

Gilles C, Schunck T, Erb G, Namer IJ, Hodé Y, Nedelec JF, Boeijinga P, Luthringer R, Mâcher JP.
PMID: 22034241
Dialogues Clin Neurosci. 2002 Dec;4(4):377-87.

Despite the growing means devoted to research and development (R α D) and refinements in the preclinical stages, the efficiency of central nervous system (CMS) drug development is disappointing. Many drugs reach patient studies with an erroneous therapeutic indication...

Cite
Gilles C, Schunck T, Erb G, et al. Human models as tools in the development of psychotropic drugs. Dialogues Clin Neurosci. 2002;4(4):377-87
Gilles, C., Schunck, T., Erb, G., Namer, I. J., Hodé, Y., Nedelec, J. F., Boeijinga, P., Luthringer, R., & Mâcher, J. P. (2002). Human models as tools in the development of psychotropic drugs. Dialogues in clinical neuroscience, 4(4), 377-87.
Gilles, Christian, et al. "Human models as tools in the development of psychotropic drugs." Dialogues in clinical neuroscience vol. 4,4 (2002): 377-87.
Gilles C, Schunck T, Erb G, Namer IJ, Hodé Y, Nedelec JF, Boeijinga P, Luthringer R, Mâcher JP. Human models as tools in the development of psychotropic drugs. Dialogues Clin Neurosci. 2002 Dec;4(4):377-87. PMID: 22034241; PMCID: PMC3181700.
Copy Download .nbib Format: NLM
A Porous TiAl6V4 Implant Material for Medical Application.

International journal of biomaterials

Deing A, Luthringer B, Laipple D, Ebel T, Willumeit R.
PMID: 25386191
Int J Biomater. 2014;2014:904230. doi: 10.1155/2014/904230. Epub 2014 Oct 16.

Increased durability of permanent TiAl6V4 implants still remains a requirement for the patient's well-being. One way to achieve a better bone-material connection is to enable bone "ingrowth" into the implant. Therefore, a new porous TiAl6V4 material was produced via...

Cite
Deing A, Luthringer B, Laipple D, et al. A Porous TiAl6V4 Implant Material for Medical Application. Int J Biomater. 2014;2014:904230doi: 10.1155/2014/904230.
Deing, A., Luthringer, B., Laipple, D., Ebel, T., & Willumeit, R. (2014). A Porous TiAl6V4 Implant Material for Medical Application. International journal of biomaterials, 2014904230. https://doi.org/10.1155/2014/904230
Deing, Axel, et al. "A Porous TiAl6V4 Implant Material for Medical Application." International journal of biomaterials vol. 2014 (2014): 904230. doi: https://doi.org/10.1155/2014/904230
Deing A, Luthringer B, Laipple D, Ebel T, Willumeit R. A Porous TiAl6V4 Implant Material for Medical Application. Int J Biomater. 2014;2014:904230. doi: 10.1155/2014/904230. Epub 2014 Oct 16. PMID: 25386191; PMCID: PMC4214099.
Copy Download .nbib Format: NLM
Evolution of life cycles and reproductive traits: Insights from the brown algae.

Journal of evolutionary biology

Heesch S, Serrano-Serrano M, Barrera-Redondo J, Luthringer R, Peters AF, Destombe C, Cock JM, Valero M, Roze D, Salamin N, Coelho SM.
PMID: 34096650
J Evol Biol. 2021 Jul;34(7):992-1009. doi: 10.1111/jeb.13880. Epub 2021 Jun 23.

A vast diversity of types of life cycles exists in nature, and several theories have been advanced to explain how this diversity has evolved and how each type of life cycle is retained over evolutionary time. Here, we exploited...

Cite
Heesch S, Serrano-Serrano M, Barrera-Redondo J, et al. Evolution of life cycles and reproductive traits: Insights from the brown algae. J Evol Biol. 2021;34(7):992-1009doi: 10.1111/jeb.13880.
Heesch, S., Serrano-Serrano, M., Barrera-Redondo, J., Luthringer, R., Peters, A. F., Destombe, C., Cock, J. M., Valero, M., Roze, D., Salamin, N., & Coelho, S. M. (2021). Evolution of life cycles and reproductive traits: Insights from the brown algae. Journal of evolutionary biology, 34(7), 992-1009. https://doi.org/10.1111/jeb.13880
Heesch, Svenja, et al. "Evolution of life cycles and reproductive traits: Insights from the brown algae." Journal of evolutionary biology vol. 34,7 (2021): 992-1009. doi: https://doi.org/10.1111/jeb.13880
Heesch S, Serrano-Serrano M, Barrera-Redondo J, Luthringer R, Peters AF, Destombe C, Cock JM, Valero M, Roze D, Salamin N, Coelho SM. Evolution of life cycles and reproductive traits: Insights from the brown algae. J Evol Biol. 2021 Jul;34(7):992-1009. doi: 10.1111/jeb.13880. Epub 2021 Jun 23. PMID: 34096650.
Copy Download .nbib Format: NLM
fMRI in anxiety.

Dialogues in clinical neuroscience

Schunck T, Erb G, Gilles C, Hode Y, Namer IJ, Fuder H, Luthringer R.
PMID: 22033750
Dialogues Clin Neurosci. 2003 Sep;5(3):246-7.

No abstract available.

Cite
Schunck T, Erb G, Gilles C, et al. fMRI in anxiety. Dialogues Clin Neurosci. 2003;5(3):246-7
Schunck, T., Erb, G., Gilles, C., Hode, Y., Namer, I. J., Fuder, H., & Luthringer, R. (2003). fMRI in anxiety. Dialogues in clinical neuroscience, 5(3), 246-7.
Schunck, Thérèse, et al. "fMRI in anxiety." Dialogues in clinical neuroscience vol. 5,3 (2003): 246-7.
Schunck T, Erb G, Gilles C, Hode Y, Namer IJ, Fuder H, Luthringer R. fMRI in anxiety. Dialogues Clin Neurosci. 2003 Sep;5(3):246-7. PMID: 22033750; PMCID: PMC3181634.
Copy Download .nbib Format: NLM
Current status of pelvic lymph node dissection in prostate cancer.

Journal of robotic surgery

Aleksic I, Luthringer T, Mouraviev V, Albala DM.
PMID: 27637231
J Robot Surg. 2014 Mar;8(1):1-6. doi: 10.1007/s11701-013-0439-7. Epub 2013 Dec 11.

Pelvic lymph node dissection (PLND) is presently considered the gold standard for the detection of lymph node invasion in prostate cancer (PCa) patients. Controversy exists over the adequate extent of PLND for patients at different stages of PCa and...

Cite
Aleksic I, Luthringer T, Mouraviev V, et al. Current status of pelvic lymph node dissection in prostate cancer. J Robot Surg. 2013;8(1):1-6doi: 10.1007/s11701-013-0439-7.
Aleksic, I., Luthringer, T., Mouraviev, V., & Albala, D. M. (2014). Current status of pelvic lymph node dissection in prostate cancer. Journal of robotic surgery, 8(1), 1-6. https://doi.org/10.1007/s11701-013-0439-7
Aleksic, Ilija, et al. "Current status of pelvic lymph node dissection in prostate cancer." Journal of robotic surgery vol. 8,1 (2014): 1-6. doi: https://doi.org/10.1007/s11701-013-0439-7
Aleksic I, Luthringer T, Mouraviev V, Albala DM. Current status of pelvic lymph node dissection in prostate cancer. J Robot Surg. 2014 Mar;8(1):1-6. doi: 10.1007/s11701-013-0439-7. Epub 2013 Dec 11. PMID: 27637231.
Copy Download .nbib Format: NLM
Common Features of Regulatory T Cell Specialization During Th1 Responses.

Frontiers in immunology

Littringer K, Moresi C, Rakebrandt N, Zhou X, Schorer M, Dolowschiak T, Kirchner F, Rost F, Keller CW, McHugh D, LeibundGut-Landmann S, Robinson MD, Joller N.
PMID: 29951069
Front Immunol. 2018 Jun 13;9:1344. doi: 10.3389/fimmu.2018.01344. eCollection 2018.

CD4

Cite
Littringer K, Moresi C, Rakebrandt N, et al. Common Features of Regulatory T Cell Specialization During Th1 Responses. Front Immunol. 2018;9:1344doi: 10.3389/fimmu.2018.01344.
Littringer, K., Moresi, C., Rakebrandt, N., Zhou, X., Schorer, M., Dolowschiak, T., Kirchner, F., Rost, F., Keller, C. W., McHugh, D., LeibundGut-Landmann, S., Robinson, M. D., & Joller, N. (2018). Common Features of Regulatory T Cell Specialization During Th1 Responses. Frontiers in immunology, 91344. https://doi.org/10.3389/fimmu.2018.01344
Littringer, Katharina, et al. "Common Features of Regulatory T Cell Specialization During Th1 Responses." Frontiers in immunology vol. 9 (2018): 1344. doi: https://doi.org/10.3389/fimmu.2018.01344
Littringer K, Moresi C, Rakebrandt N, Zhou X, Schorer M, Dolowschiak T, Kirchner F, Rost F, Keller CW, McHugh D, LeibundGut-Landmann S, Robinson MD, Joller N. Common Features of Regulatory T Cell Specialization During Th1 Responses. Front Immunol. 2018 Jun 13;9:1344. doi: 10.3389/fimmu.2018.01344. eCollection 2018. PMID: 29951069; PMCID: PMC6008317.
Copy Download .nbib Format: NLM
Surface Functionalization of Biomedical Ti-6Al-7Nb Alloy by Liquid Metal Dealloying.

Nanomaterials (Basel, Switzerland)

Okulov IV, Joo SH, Okulov AV, Volegov AS, Luthringer B, Willumeit-Römer R, Zhang L, Mädler L, Eckert J, Kato H.
PMID: 32731588
Nanomaterials (Basel). 2020 Jul 28;10(8). doi: 10.3390/nano10081479.

Surface functionalization is an effective approach to change the surface properties of a material to achieve a specific goal such as improving the biocompatibility of the material. Here, the surface of the commercial biomedical Ti-6Al-7Nb alloy was functionalized through...

Cite
Okulov IV, Joo SH, Okulov AV, et al. Surface Functionalization of Biomedical Ti-6Al-7Nb Alloy by Liquid Metal Dealloying. Nanomaterials (Basel). 2020;10(8)doi: 10.3390/nano10081479.
Okulov, I. V., Joo, S. H., Okulov, A. V., Volegov, A. S., Luthringer, B., Willumeit-Römer, R., Zhang, L., Mädler, L., Eckert, J., & Kato, H. (2020). Surface Functionalization of Biomedical Ti-6Al-7Nb Alloy by Liquid Metal Dealloying. Nanomaterials (Basel, Switzerland), 10(8), . https://doi.org/10.3390/nano10081479
Okulov, Ilya Vladimirovich, et al. "Surface Functionalization of Biomedical Ti-6Al-7Nb Alloy by Liquid Metal Dealloying." Nanomaterials (Basel, Switzerland) vol. 10,8 (2020). doi: https://doi.org/10.3390/nano10081479
Okulov IV, Joo SH, Okulov AV, Volegov AS, Luthringer B, Willumeit-Römer R, Zhang L, Mädler L, Eckert J, Kato H. Surface Functionalization of Biomedical Ti-6Al-7Nb Alloy by Liquid Metal Dealloying. Nanomaterials (Basel). 2020 Jul 28;10(8). doi: 10.3390/nano10081479. PMID: 32731588; PMCID: PMC7466585.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries